-
ICD-10-CM Codes
›
-
Z00-Z99
›
-
Z19-Z19
›
-
Z19-
›
-
2023 ICD-10-CM Diagnosis Code Z19
2023 ICD-10-CM Diagnosis Code Z19
Hormone sensitivity malignancy status
2017 - New Code 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
- Z19 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2023 edition of ICD-10-CM Z19 became effective on October 1, 2022.
- This is the American ICD-10-CM version of Z19 - other international versions of ICD-10 Z19 may differ.
Code FirstCode First Help
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere." Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition.
- malignant neoplasm - see Table of Neoplasms, by site, malignant
The following code(s) above
Z19 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
Z19:
Code History
- 2017 (effective 10/1/2016): New code
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
ICD-10-CM Codes Adjacent To Z19
Z18.3 Retained organic fragments
Z18.31 Retained animal quills or spines
Z18.33 Retained wood fragments
Z18.39 Other retained organic fragments
Z18.8 Other specified retained foreign body
Z18.81 Retained glass fragments
Z18.83 Retained stone or crystalline fragments
Z18.9 Retained foreign body fragments, unspecified material
Z19
Hormone sensitivity malignancy status
Z19.1 Hormone sensitive malignancy status
Z19.2 Hormone resistant malignancy status
Z20 Contact with and (suspected) exposure to communicable diseases
Z20.0 Contact with and (suspected) exposure to intestinal infectious diseases
Z20.01 …… due to Escherichia coli (E. coli)
Z20.09 Contact with and (suspected) exposure to other intestinal infectious diseases
Z20.1 Contact with and (suspected) exposure to tuberculosis
Z20.2 Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission
Z20.3 Contact with and (suspected) exposure to rabies
Z20.4 Contact with and (suspected) exposure to rubella
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.